InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-39.3%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Newton Todd, Director. Director active across 1 company, notably Mimedx Group, INC.. Cumulatively, 6 disclosures have been published. Activity tracked since 27 May 2021. The latest transaction was disclosed on 5 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
23,190 shares@ US$7.2620.2% of flowCommon StockSEC:0001376339-24-000048:0
35,354 shares@ US$4.9521.1% of flowCommon StockSEC:0001376339-23-000037:0
200,000 shares0Common StockSEC:0001376339-22-000116:0
44,191 shares@ US$3.960.016% mcap36.3% of flowCommon StockSEC:0001376339-22-000093:0
17,056 shares@ US$10.260.014% mcap31.9% of flowCommon StockSEC:0001376339-21-000079:0
17,056 shares@ US$10.2631.9% of flowCommon StockSEC:0001376339-21-000079
6 of 6 declarations
About Newton Todd
Newton Todd is a Board Member at MIMEDX GROUP, INC. He plays a key role in the governance of the company and in formulating its strategies. His experience in the biotechnology sector is a valuable asset.
